Albumin Substitution in Decompensated Liver Cirrhosis: Don’t Forget Zinc

Decompensated liver cirrhosis has a dismal prognosis, with patients surviving on average for 2–4 years after the first diagnosis of ascites. Albumin is an important tool in the therapy of cirrhotic ascites. By virtue of its oncotic properties, it reduces the risk of cardiovascular dysfunction after...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Kurt Grüngreiff, Thomas Gottstein, Dirk Reinhold, Claudia A. Blindauer
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
Acceso en línea:https://doaj.org/article/a20f9cfe3ead4174bc1a66af0e573311
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares